Investment Thesis
IMAX exhibits fundamental stagnation with zero revenue growth and critically poor capital efficiency (ROE 1.3%, ROA 0.5%), indicating the company is not creating shareholder value despite a fortress balance sheet. The anemic free cash flow of $1.9M and deteriorating returns on invested capital in a structurally challenged sector suggest ongoing value erosion.
Strengths
- Zero long-term debt and fortress balance sheet with $146M cash provides defensive financial stability
- Exceptional gross margins of 56.3% demonstrate operational efficiency and pricing power within the business
- Net income grew 39.2% YoY through improved cost discipline and operational efficiency
Risks
- Revenue completely flat at 0.0% YoY with no visible growth catalysts in a challenged photographic equipment sector
- Exceptionally poor capital efficiency with ROE of only 1.3% and ROA of 0.5% indicates severe capital deployment failures
- Anemic free cash flow of $1.9M represents only 45% of net income conversion, signaling weak business quality
- Photographic equipment sector faces structural secular decline from digital disruption and shifting business models
Key Metrics to Watch
- Revenue growth rate - must achieve positive growth to demonstrate business viability
- Return on equity trajectory - critical improvement needed to justify capital employed
- Free cash flow generation and conversion rate - must strengthen to validate earnings quality
Financial Metrics
Revenue
81.4M
Net Income
4.2M
EPS (Diluted)
$0.07
Free Cash Flow
1.9M
Total Assets
893.2M
Cash
146.0M
Profitability Ratios
Gross Margin
56.3%
Operating Margin
12.2%
Net Margin
5.2%
ROE
1.3%
ROA
0.5%
FCF Margin
2.3%
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
52.0%
Interest Coverage
5.12x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T11:20:17.851064 |
Data as of: 2026-03-31 |
Powered by Claude AI